Keywords: glenmark, forest, pde4, inhibitor, deal, pharmaceuticals, sa

Glenmark and Forest in PDE4 inhibitor deal

Article | 04 October 2004

Glenmark Pharmaceuticals SA (Switzerland), a wholly-owned subsidiary of Glenmark Pharmaceuticals India, and USA-based Forest Laboratories have entered into a collaborative ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Forest Laboratories

Go to company listing